AURICCHIO, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 1.679
EU - Europa 819
AS - Asia 541
AF - Africa 17
OC - Oceania 4
SA - Sud America 4
Totale 3.064
Nazione #
US - Stati Uniti d'America 1.636
SG - Singapore 334
IT - Italia 205
UA - Ucraina 205
CN - Cina 187
DE - Germania 137
FI - Finlandia 105
IE - Irlanda 63
CA - Canada 43
GB - Regno Unito 30
NL - Olanda 28
CI - Costa d'Avorio 17
SE - Svezia 14
CZ - Repubblica Ceca 11
FR - Francia 11
TR - Turchia 9
IN - India 6
IR - Iran 4
NZ - Nuova Zelanda 4
PL - Polonia 3
BR - Brasile 2
AR - Argentina 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
MK - Macedonia 1
Totale 3.064
Città #
Chandler 337
Singapore 275
Jacksonville 224
Princeton 91
Millbury 85
Ashburn 76
Nanjing 65
Santa Clara 59
Wilmington 52
Napoli 48
Ottawa 40
Naples 36
Boston 34
Beijing 28
Amsterdam 25
Nanchang 19
Munich 17
Hebei 12
Kronberg 12
Norwalk 12
Des Moines 11
Shenyang 11
Boardman 10
Jiaxing 10
Brno 9
Falls Church 9
Helsinki 9
Changsha 8
Hanover 8
Orange 8
Salerno 7
Agropoli 6
Lawrence 6
Tianjin 6
Tekirdağ 5
Milan 4
New York 4
Papamoa 4
San Mateo 4
Indiana 3
Lappeenranta 3
Lizzanello 3
London 3
Ningbo 3
Pozzuoli 3
Redmond 3
Rome 3
Toronto 3
Verona 3
Ardabil 2
Berlin 2
Dallas 2
Dublin 2
Formia 2
Frankfurt am Main 2
Hangzhou 2
Kraków 2
Leawood 2
Manchester 2
Mumbai 2
Nuremberg 2
Pescara 2
Pune 2
Rotterdam 2
San Giorgio del Sannio 2
San Pietro di Feletto 2
Sandston 2
Simi Valley 2
Sondrio 2
Taizhou 2
Treviso 2
Vracov 2
Zhengzhou 2
Acerra 1
Ann Arbor 1
Arosio 1
Aubervilliers 1
Berceto 1
Brescia 1
Budapest 1
Buenos Aires 1
Casalnuovo di Napoli 1
Castellammare di Stabia 1
Civitavecchia 1
Cologne 1
Dearborn 1
Fairfield 1
Ferrara di Monte Baldo 1
Florence 1
Fuzhou 1
Genova 1
Guangzhou 1
Hefei 1
Idaho Falls 1
Jinan 1
Kunming 1
Lanzhou 1
Los Ángeles 1
Madrid 1
Maywood 1
Totale 1.791
Nome #
Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. 67
A Celiac Cellular Phenotype, with Altered LPP Sub-Cellular Distribution, Is Inducible in Controls by the Toxic Gliadin Peptide P31-43. 53
Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects 52
Clinical, HLA and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. 51
Inflammation Is Present, Persistent and More Sensitive to Proinflammatory Triggers in Celiac Disease Enterocytes 49
Susceptibility to deamidation by tissue transglutaminase as a tool to identify immunogenic gliadin peptides in the whole gliadin extracts 47
Amines Protect Invitro the Celiac Small-intestine From the Damaging Activity of Gliadin Peptides 46
Adaptive and innate immune responses in celiac disease. 45
Characterization of the anti-tissue transglutaminase antibody response in non-obese diabetic mice. 45
Gliadin peptide P31-43 localizes to endocytic vesicles and interferes with their maturation. 45
The toxic alpha-gliadin peptide 31–43 enters cells without a surface membrane receptor 45
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. 44
Interleukin-10 downregulates inflammation in the small intestinal mucosa of patients with potential celiac disease. 44
Safety for Patients With Celiac Disease of Baked Goods Made of Wheat Flour Hydrolyzed During Food Processing 44
Adjuvant effect of lactobacillus casei in a mouse model of gluten sensitivity. 43
CELL SHAPE DISCRIMINATES BETWEEN NORMAL AND CELIAC DISEASE (CD) DENDRITIC CELLS (DC). 42
An undigested gliadin peptide activates innate immunity and proliferative signalling in enterocytes: the role in celiac disease 42
Immunogenicity of monococcum wheat in celiac patients 42
SERUM IMMUNOGLOBULINS A AND G, AND MONOCLONAL ANTIBODIES ANTI TISSUE TRANSGLUTAMINASE FROM COELIAC PATIENTS INHIBIT THE CATALYTIC ACTIVITY BOTH IN VITRO AND IN SITU 41
M.V. Barone, M. Nanayakkara, D. Zanzi, S. Santagata, G. Lania, V. Discepolo, M. Ten-Eikelder, S. Auricchio 41
GLIADIN PEPTIDE P31-43 PRESENTS IL15 IN TRANS TO THE NEIGHBOURING CELLS 41
celiac disease assocition with CD8+ T cell responses: identification of a novel gliadin-derived hla-a2 restricted epitope. 40
Both innate immunity and growth factor receptor (EGFR) contribute to P31-43 induced proliferation effects in CACO2 cells and celiac enterocytes. 40
Potential celiac patients: a model of celiac disease pathogenesis. 40
Recombinant human IL-10 suppreses gliadin-dependent T-cell activation in ex vivo cultured celiac intestinal mucosa. 39
Gliadin peptide P31-43 interferes Hrs (hepatocyte growth factor-regulated tyrosine kinasesubstrate) localization to endocytic vesicles: implications for Celiac Disease (CD) 39
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells. 39
Pediatric celiac disease patients show alterations of dendritic cell shape and actin rearrangement 39
Gliadin activates HLA class I-restricted CD8+ cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis. 38
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 epithelial cells. 38
Immunogenic peptides can be detected in whole gluten by transamidating highly susceptible glutamine residues: implication in the search for gluten-free cereals 38
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease 37
Blockage of T-cell costimulation inhibits T-cell action in celiac disease 37
Celiac autoantibodies to tissue transglutaminase modulate alpha-gliadin peptide 31-43 uptake by epithelial cells. 37
Gliadin peptide P31-43 interferes with Hrs localization to endocytic vesicles 37
Rotavirus and celiac disease: clues to the pathogenesis and perspectives on prevention. 35
ANTI TISSUE TRANSGLUTAMINASE ANTIBODIES FROM COELIAC PATIENTS INHIBIT TRANSGLUTAMINASE ACTIVITY BOTH IN VITRO AND IN SITU. 35
Altered trafficking of EGF in endocytic proliferation and innate immunity markers in MARSH 0 (M0) biopsies of celiac patients. 35
Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten. 35
P31-43, an undigested gliadin peptide, mimics and enhances the innate immune response to viruses and interferes with endocytic trafficking: A role in celiac disease 35
Constitutive alterations in vesicular trafficking increase the sensitivity of cells from celiac disease patients to gliadin 35
Small intestinal enteropathy in non-obese diabetic mice fed a diet containing wheat. 34
Flow cytometric and immunohistochemical analysis reveal an increase of CD4+ CD25+ FOXP3+ regulatory T cells in the small intestinal mucosa of potential and untreated coeliac patients. 34
AN IMMUNODOMINANT DQ8 RESTRICTED GLIADIN PEPTIDE ACTIVATES SMALL INTESTINAL IMMUNE RESPONSE IN "IN VITRO" CULTURED MUCOSA FROM HLA-DQ8 POSITIVE BUT NOT HLA-DQ8 NEGATIVE CELIAC PATIENTS. 33
Intravenous or intranasal administrtion of gliadin is able to down-regulate the specific immune response in mice. 32
Gliadin-specific type 1 regulatory T-cells from the intestinal mucosa of treated coeliac patients inhibit pathogenic T-cells. 31
Transglutaminase 2 in coeliac disease. 30
EVIDENCE OF CHRONIC INFLAMMATION IN MORPHOLOGICALLY NORMAL SMALL INTESTINE OF CYSTIC FIBROSIS PATIENTS. 30
Arylamidase activities of brushborder membrane of rat intestine 30
Automic dysfunction in children with hirschsprung's disease. 29
Celiac disease patients dendritic cells have a different shape when interacting with the substrate compared to controls. 29
In Celiac Disease Patients the In Vivo Challenge with the Diploid Triticum monococcum Elicits a Reduced Immune Response Compared to Hexaploid Wheat 29
Enhanced expression of interferon regulatory factor-1 in the mucosa children with coeliac disease. 28
Gluten sensitivy in a subset of children with insuli-dependent diabetes mellitus. 28
Low risk of colon cancer in patients with celiac disease 28
Gliadin-Specific CD8(+) T Cell Responses Restricted by HLA Class I A*0101 and B*0801 Molecules in Celiac Disease Patients 28
Sourdough Bread Made from Wheat and Nontoxic Flours and Started with Selected Lactobacilli Is Tolerated in Celiac Sprue Patients. 27
Dietary proteins and mechanism of gastrointestinal disease: gliadin as a model. 26
Possible drug targets for coeliac disease. 26
FOXP3+ regulatory T-cells are increased in the untreated celiac mucosa and are expanded by gliadin in the in vitro cultured treated mucosa. 26
Gliadin peptide P31-43 presents in trans IL15. 26
Brush border and cytosol peptidase activities of human small intestine in normal subjects and celiac patients. 26
Enzymaticactivity hydrolyzing -glutamyl- -naphthylamide in human intestine during adultand fetal life 26
IL-15 drives the specific migration of CD94+ and TCR-gamma delta+ intraepithelial lymphocites in organ cultures of treated celiac patients 25
ZONULA OCCLUDENS TOXIN (ZOT) INTERFERES WITH THE INDUCION OF NASAL TOLERANCE TO GLIADIN. 25
Celiac disease: role of intestinal compartments in the mucosal immune response. 25
The gut as site of production of autoimmune antibodies. 24
Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of coeliac patients 24
Gliadin activates mucosal cell-mediated immunity in in vitro cultured rectal mucosa from coeliac patients and a subset of their siblings 24
Production of antiendomysial antibodies after in vitro gliadin challenge of small intestinal biopsy samples from patients with coeliac disease 24
In siblings of coeliac children rectal gluten challenge reveals sensitisation to gluten not restricted to coeliac HLA 24
INTRANASAL ADMINISTRATION OF ONE ALPHA GLIADIN CAN DOWNREGULATE THE IMMUNE RESPONSE TO WHOLE GLIADIN IN MICE. 24
Terapia del reflusso gastroesofageo 24
Colite ulcerosa e colite allergica 24
GLIADIN P31-43 PEPTIDE CAN DELAY EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR) DECAY INTERIFERING WITH THE ENDOCYTIC PATHWAY 24
Pivotal Role of Inflammation in Celiac Disease 23
INTERLEUKIN 18 ASSOCIATED MARKERS OF T HELPER CELL TYPE 1 ACTIVITY IN COELIAC DISEASE. 23
Gliadin regulates the NK-dendritic cross-talk by HLA-E surface stabilization 23
Interleukin 15 mediated epithelial changes in celiac disease 23
FAS engagement drives apostosis of enterocytes of coeliac patients 22
Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. 22
EXPRESSION AND ENZYMATIC ACTIVITY OF TRANSGLUTAMINASE IN THE NORMAL AND COELIAC DISEASE 22
Dietary proteins and mechanisms of gastrointestinal diseases: gliadin as a model. 22
In mice, intravenous or intranasal administration of gliadin is able to down-regulate the specific autoimmune response 21
Identification of immunodominant epitopes of (alpha)-gliadin in HLA-DQ8 transgenic mice following oral immunization. 20
Identification of immunodominant epitopes of {alpha}- gliadin in HLA-DQ8 transgenic mice following oral immunization. 20
Dolore addominale ricorrente ed infezione da Helicobacter pylori: un esempio di revisione critica delle conoscenze 20
Alpha-Glutamyl-beta-naphthylamide hydrolase of rabbit small intestine. Localization in the brush border and separation fromother brush border peptidases. 20
Gluten consumption and inflammation affect the development of celiac disease in at-risk children 19
Delayed diagnosis of coeliac disease increases cancer risk 19
Laser capture microdissection as a tool to study the mucosal immune response in celiac disease 19
Antibody Profile, Gene Expression and Serum Cytokines in At-Risk Infants before the Onset of Celiac Disease 18
Fisiopatologia della motilità dell'apparato digerente nel bambino: nuove acquisizioni 18
IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in celiac disease 18
Early childhood feeding practices in southern Italy: Is the Mediterranean diet becoming obsolete? Study of 450 children aged 6-32 months in Campania, Italy 18
Chapter 8. 50 Years of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN): Captivating Witness Reports of a Success Story 18
Immunomodulatory effects of Lactobacillus casei administration in a mouse model of gliadin-sensitive enteropathy 17
Esophageal motor involvement in minimal change myopathy. 17
Correction of Gliadin Transport Within Enterocytes Through Celiac Disease Serum 16
Evidence for still ongoing convergence evolution of the lactase persistence T -13910 alleles in humans. 15
Totale 3.137
Categoria #
all - tutte 15.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020200 0 0 0 0 58 2 0 5 3 16 43 73
2020/2021359 1 41 37 41 45 53 42 0 44 1 53 1
2021/2022488 7 0 0 3 6 22 8 12 74 35 138 183
2022/2023694 105 86 27 48 85 80 3 77 117 29 24 13
2023/2024441 20 68 54 26 18 11 6 90 17 4 95 32
2024/2025454 171 208 17 9 49 0 0 0 0 0 0 0
Totale 3.210